Suppr超能文献

小脑高级别胶质瘤不存在与幕上高级别胶质瘤相同的分子改变,且可能显示组蛋白H3基因突变。

Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations.

作者信息

Tauziède-Espariat Arnault, Saffroy Raphaël, Pagès Mélanie, Pallud Johan, Legrand Laurence, Besnard Aurore, Lacombe Joëlle, Lot Guillaume, Borha Alin, Tazi Sanaa, Adle-Biassette Homa, Polivka Marc, Lechapt Emmanuèle, Varlet Pascale

出版信息

Clin Neuropathol. 2018 Sep/Oct;37(5):209-216. doi: 10.5414/NP301104.

Abstract

Numerous molecular alterations have been described in supratentorial high-grade gliomas (1p19q co-deletion, IDH1/2, histone H3, hTERT promotor mutations, loss of ATRX) which have led to a new histomolecular classification of diffuse gliomas. We aimed at describing these alterations in a series of 19 adults with pure cerebellar high-grade gliomas. Systematic immunohistochemical analyses, including that of IDH1R132H, ATRX, p53, PTEN, EGFR, p16, FGFR3, BRAFV600E, mismatch repair proteins, H3K27me3, H3K36me3, and H3K27M; molecular analyses of IDH1/2, hTERT, BRAF, H3F3A, and HIST1H3B mutation hotspots; and EGFR, PTEN FISH were retrospectively performed in a multicentric study. We histopathologically identified 14 glioblastomas, 4 grade III astrocytomas and 1 gliosarcoma. Two cases showed a H3F3A K27M mutation. Only one case harbored a classical profile of glioblastoma with hTERT mutation, EGFR gain and 10q loss. The most frequent alteration was the absence of p16 immunoexpression. We report a histomolecular analysis of pure cerebellar high grade gliomas. The histomolecular profile appears to be different from that of supratentorial gliomas, with no IDH1/2 gene mutations and only 1 case with a classic profile of de novo glioblastoma. In 2 cases, we identified H3F3A K27M mutation, classically described in pediatric midline gliomas.
.

摘要

幕上高级别胶质瘤中已描述了众多分子改变(1p19q 共缺失、异柠檬酸脱氢酶 1/2(IDH1/2)、组蛋白 H3、端粒酶逆转录酶(hTERT)启动子突变、α地中海贫血/智力发育迟缓综合征 X 连锁基因(ATRX)缺失),这些改变促成了弥漫性胶质瘤的新组织分子分类。我们旨在描述 19 例纯小脑高级别胶质瘤成年患者的这些改变。在一项多中心研究中,回顾性地进行了系统免疫组化分析,包括对 IDH1R132H、ATRX、p53、磷酸酶和张力蛋白同源物(PTEN)、表皮生长因子受体(EGFR)、p16、成纤维细胞生长因子受体 3(FGFR3)、BRAF 基因 V600E 突变、错配修复蛋白、组蛋白 H3 赖氨酸 27 三甲基化(H3K27me3)、组蛋白 H3 赖氨酸 36 三甲基化(H3K36me3)和组蛋白 H3 赖氨酸 27 单甲基化(H3K27M)的分析;对 IDH1/2、hTERT、BRAF、组蛋白 H3 家族成员 3A(H3F3A)和 HIST1H3B 突变热点的分子分析;以及 EGFR、PTEN 荧光原位杂交(FISH)。我们通过组织病理学鉴定出 14 例胶质母细胞瘤、4 例三级星形细胞瘤和 1 例胶质肉瘤。2 例显示 H3F3A K27M 突变。仅 1 例具有胶质母细胞瘤的典型特征,伴有 hTERT 突变、EGFR 扩增和 10q 缺失。最常见的改变是 p16 免疫表达缺失。我们报告了纯小脑高级别胶质瘤的组织分子分析。其组织分子特征似乎与幕上胶质瘤不同,无 IDH1/2 基因突变,仅有 1 例具有新发胶质母细胞瘤的典型特征。在 2 例中,我们鉴定出 H3F3A K27M 突变,这在儿童中线胶质瘤中经典描述。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验